These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 32306042)

  • 1. Testing for SARS-CoV-2: Can We Stop at 2?
    Lee TH; Junhao Lin R; Lin RTP; Barkham T; Rao P; Leo YS; Chien Lye D; Young B;
    Clin Infect Dis; 2020 Nov; 71(16):2246-2248. PubMed ID: 32306042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel testing of 241 clinical nasopharyngeal swabs for the detection of SARS-CoV-2 virus on the Cepheid Xpert Xpress SARS-CoV-2 and the Roche cobas SARS-CoV-2 assays.
    Tham JWM; Ng SC; Chai CN; Png S; Tan EJM; Ng LJ; Chua RP; Sani M; Chiang D; Tan KX; Tee NWS; Jureen R; Tan SS; Yan G; Yan B; Lee CK
    Clin Chem Lab Med; 2020 Nov; 59(2):e45-e48. PubMed ID: 33554503
    [No Abstract]   [Full Text] [Related]  

  • 3. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
    Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
    Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system.
    Thwe PM; Ren P
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115228. PubMed ID: 33190093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two nasal swabs may not be enough to exclude SARS-CoV-2 infection in symptomatic patients.
    Fiore JR; D'Errico M; Bottalico I; Rizzo M; Montemurro L; Lo Caputo S; Faleo G; Di Stefano M; Santantonio T
    Ann Ig; 2021; 33(3):297-298. PubMed ID: 33739360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of SARS CoV-2 detection by real-time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: a study in tertiary care hospital of North India.
    Chhikara K; Kanta P; Ghosh A; Prakash RC; Goyal K; Singh MP
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115206. PubMed ID: 33045499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraction-Free Methods for the Detection of SARS-CoV-2 by Reverse Transcription-PCR: a Comparison with the Cepheid Xpert Xpress SARS-CoV-2 Assay across Two Medical Centers.
    Cameron A; Pecora ND; Pettengill MA
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33184055
    [No Abstract]   [Full Text] [Related]  

  • 8. Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction.
    Beltrán-Pavez C; Alonso-Palomares LA; Valiente-Echeverría F; Gaggero A; Soto-Rifo R; Barriga GP
    J Virol Methods; 2021 Jan; 287():113969. PubMed ID: 32918932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients.
    Kandel C; Zheng J; McCready J; Serbanescu MA; Racher H; Desaulnier M; Powis JE; Vojdani K; Finlay L; Sheldrake E; Vermeiren C; Katz K; McGeer A; Kozak R; Goneau LW
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33212817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Nasopharyngeal Swab Testing-False-Negative Results From a Pervasive Anatomical Misconception.
    Higgins TS; Wu AW; Ting JY
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):993-994. PubMed ID: 32940647
    [No Abstract]   [Full Text] [Related]  

  • 11. Pooling samples: a testing option for SARS-CoV-2 during a supply shortage.
    Salimnia H; Mitchell R; Gundel A; Cambell A; Gammou F; Chopra T; Fairfax M
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115205. PubMed ID: 33190092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR.
    Torres I; Albert E; Navarro D
    J Med Virol; 2020 Nov; 92(11):2306-2307. PubMed ID: 32369202
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
    Lephart PR; Bachman MA; LeBar W; McClellan S; Barron K; Schroeder L; Newton DW
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115200. PubMed ID: 32980807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.
    Serei VD; Cristelli R; Joho K; Salaru G; Kirn T; Carayannopoulous MO; Uprety P
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115208. PubMed ID: 33545455
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection.
    Liotti FM; Menchinelli G; Marchetti S; Morandotti GA; Sanguinetti M; Posteraro B; Cattani P
    Clin Microbiol Infect; 2020 Dec; 26(12):1699-1700. PubMed ID: 32735938
    [No Abstract]   [Full Text] [Related]  

  • 16. When Clinicians Should Repeat RT-PCR for SARS-CoV-2: Repeat PCR Testing in Patients with Pulmonary CT Findings Suggestive of COVID-19.
    Yamamoto K; Saito S; Hayakawa K; Hashimoto M; Takasaki J; Ohmagari N
    Jpn J Infect Dis; 2021 Mar; 74(2):161-165. PubMed ID: 32863359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooling for SARS-CoV-2-testing: comparison of three commercially available RT-qPCR kits in an experimental approach.
    Cibali E; Wenzel JJ; Gruber R; Ambrosch A
    Clin Chem Lab Med; 2021 May; 59(6):e243-e245. PubMed ID: 33470953
    [No Abstract]   [Full Text] [Related]  

  • 18. LamPORE SARS-CoV-2 diagnosis and genotyping: A preliminary report.
    Morsli M; Anani H; Bréchard L; Delerce J; Bedotto M; Fournier PE; Drancourt M
    J Clin Virol; 2021 May; 138():104815. PubMed ID: 33838620
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of three commercial SARS-CoV-2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics.
    Ho YI; Wong AH; Tang KPS; Wong RCW; Leung ECM; Lai RWM
    J Med Virol; 2021 Apr; 93(4):1917-1919. PubMed ID: 33428782
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitivity of SARS-CoV-2 Detection With Nasopharyngeal Swabs.
    Clerici B; Muscatello A; Bai F; Pavanello D; Orlandi M; Marchetti GC; Castelli V; Casazza G; Costantino G; Podda GM
    Front Public Health; 2020; 8():593491. PubMed ID: 33575241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.